A law firm representing hospitals and other 340B covered entities across the U.S. has called on more than two dozen [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A Vermont Democrat has introduced Senate legislation to codify providers’ ability to use contract pharmacies to dispense 340B discounted drugs, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Exclusive
Welch Likely to Introduce Senate Version of Matsui’s 340B PATIENTS Act As Soon As Next Week
A Vermont Democrat and longtime 340B advocate is expected to soon introduce a Senate version of the 340B Pharmaceutical Access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson (J&J) has ended its contract pharmacy restrictions for covered entities in Arkansas, making the New Jersey-based pharmaceutical [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Boston-based biopharmaceutical company will soon extend its contract pharmacy restrictions from hospitals to all 340B covered entities (CEs), except [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...] …